TGF-β, radiation-induced pulmonary injury and lung cancerVUJASKOVIC, Z; GROEN, H. J. M.International journal of radiation biology (Print). 2000, Vol 76, Num 4, pp 511-516, issn 0955-3002Conference Paper

Chemotherapy in elderly small-cell lung cancer patients: yes we can, but should we do it?JANSSEN- HEIJNEN, M. L. G; MAAS, H. A. A. M; VAN DE SCHANS, S. A. M et al.Annals of oncology. 2011, Vol 22, Num 4, pp 821-826, issn 0923-7534, 6 p.Article

Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trialNAVANI, N; NANKIVELL, M; STEPHENS, R. J et al.Thorax. 2010, Vol 65, Num 5, issn 0040-6376, p. 463Article

A randomised phase II trial of docetaxel vs docetaxel and irinotecan in patients with stage IIIb-IV non-small-cell lung cancer who failed first-line treatmentWACHTERS, F. M; GROEN, H. J. M; BIESMA, B et al.British journal of cancer. 2005, Vol 92, Num 1, pp 15-20, issn 0007-0920, 6 p.Article

ERCC1, hRad51, and BRCA1 protein expression in relation to tumour response and survival of stage III/IV NSCLC patients treated with chemotherapyWACHTERS, F. M; WONG, L. S. M; TIMENS, W et al.Lung cancer. 2005, Vol 50, Num 2, pp 211-219, issn 0169-5002, 9 p.Article

Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III studyGROEN, H. J. M; VAN DER LEEST, A. H. W; VAN PUTTEN, J. W. G et al.Annals of oncology. 2004, Vol 15, Num 3, pp 427-432, issn 0923-7534, 6 p.Article

Oesophageal endoscopic ultrasound with fine needle aspiration improves and simplifies the staging of lung cancerKRAMER, H; VAN PUTTEN, J. W. G; POST, W. J et al.Thorax. 2004, Vol 59, Num 7, pp 596-601, issn 0040-6376, 6 p.Article

Preoperative staging of non-small-cell lung cancer with positron-emission tomographyPIETERMAN, R. M; VAN PUTTEN, J. W. G; MEUZELAAR, J. J et al.The New England journal of medicine. 2000, Vol 343, Num 4, pp 254-261, issn 0028-4793Article

A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimensMEERSMA, G. J; BAKKER, M; GROEN, H. J. M et al.Anticancer research. 1999, Vol 19, Num 2A, pp 1309-1315, issn 0250-7005Article

Approaches to lung cancer treatment using the CD3ExGP-2-directed bispecific monoclonal antibody BIS-1KROESEN, B. J; NIEKEN, J; SLEIJFER, D. T et al.Cancer immunology and immunotherapy. 1997, Vol 45, Num 3-4, pp 203-206, issn 0340-7004Conference Paper

Pulmonary tumours in the Netherlands : focus on temporal trends in histology and stage and on rare tumoursDE JONG, W. K; SCHAAPVELD, M; BLAAUWGEERS, J. L. G et al.Thorax. 2008, Vol 63, Num 12, pp 1096-1102, issn 0040-6376, 7 p.Article

Endoscopic ultrasound-guided fine-needle aspiration in patients with mediastinal abnormalities and previous extrathoracic malignancyKRAMER, H; KOËTER, G. H; SLEIJFER, D. T et al.European journal of cancer (1990). 2004, Vol 40, Num 4, pp 559-562, issn 0959-8049, 4 p.Article

Expression of apoptosis-related proteins and morphological changes in a rat tumor model of human small cell lung cancer prior to and after treatment with radiotherapy, carboplatin, or combined treatmentFOKKEMA, E; DE VRIES, E. G. E; GROEN, H. J. M et al.Virchows Archiv. 2003, Vol 442, Num 4, pp 349-355, issn 0945-6317, 7 p.Article

Routine radiography does not have a role in the diagnostic evaluation of ambulatory adult febrile neutropenic cancer patientsOUDE NIJHUIS, C. S. M; GIETEMA, J. A; VELLENGA, E et al.European journal of cancer (1990). 2003, Vol 39, Num 17, pp 2495-2498, issn 0959-8049, 4 p.Article

Dose-finding and pharmacological study of ifosfamide in combination with paclitaxel and carboplatin in resistant small-cell lung cancerVAN PUTTEN, J. W. G; KERBUSH, T; SMIT, E. F et al.Annals of oncology. 2001, Vol 12, Num 6, pp 787-792, issn 0923-7534Article

Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell linesGROEN, H. J. M; SLEIJFER, S; MEIJER, C et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1406-1411, issn 0007-0920Article

Surgical resection for small cell carcinoma of the lung : a retrospective studySMIT, E. F; GROEN, H. J. M; TIMENS, W et al.Thorax. 1994, Vol 49, Num 1, pp 20-22, issn 0040-6376Article

Effects of recombinant human interleukin-6 in cancer patients : a phase I-II studyVAN GAMEREN, M. M; WILLEMSE, P. H. B; MULDER, N. H et al.Blood. 1994, Vol 84, Num 5, pp 1434-1441, issn 0006-4971Article

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancerGROEN, H. J. M; SMIT, E. F; HAAXMA-REICHE, H et al.European journal of cancer. Part A. 1993, Vol 29, Num 12, pp 1696-1699Article

A phase II study of erlotinib in combination with bevacizumab versus chemotherapy plus bevacizumab in the first-line treatment of advanced non-squamous non-small cell lung cancerCIULEANU, T; TSAI, C.-M; MIDDLETON, G et al.Lung cancer. 2013, Vol 82, Num 2, pp 276-281, issn 0169-5002, 6 p.Article

A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 studyAERTS, J. G; CODRINGTON, H; LANKHEET, N. A. G et al.Annals of oncology. 2013, Vol 24, Num 11, pp 2860-2865, issn 0923-7534, 6 p.Article

A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)GROEN, H. J. M; SOCINSKI, M. A; HARMON, C et al.Annals of oncology. 2013, Vol 24, Num 9, pp 2382-2389, issn 0923-7534, 8 p.Article

Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factorHILTERMANN, T. J. N; PORE, M. M; TISSING, H et al.Annals of oncology. 2012, Vol 23, Num 11, pp 2937-2942, issn 0923-7534, 6 p.Article

Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects : From lab to clinicDE GROOT, D. J. A; DE VRIES, E. G. E; GROEN, H. J. M et al.Critical reviews in oncology/hematology. 2007, Vol 61, Num 1, pp 52-69, issn 1040-8428, 18 p.Article

First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trialWACHTERS, F. M; VAN PUTTEN, J. W. G; KRAMER, H et al.British journal of cancer. 2003, Vol 89, Num 7, pp 1192-1199, issn 0007-0920, 8 p.Article